Bigul

Apollo Hospitals Enterprise Ltd - 508869 - Board to consider FY21 results & Dividend on June 23, 2021

Apollo Hospitals Enterprise Ltd has informed BSE that the Board of Directors of the Company will, inter alia, consider the approval of the audited financial results for the quarter and year ended March 31, 2021 and recommendation of dividend, if any, for the year ending March 31, 2021, at its Meeting to be held on June 23, 2021.Further, in accordance with the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window would continue to remain closed for Promoters, Directors, other connected persons and designated employees of the Company from April 01, 2021 till 48 hours after the announcement of financial results i.e., upto June 25, 2021.
08-06-2021
Bigul

Apollo Hospitals Enterprise Ltd - 508869 - Closure of Trading Window

Further to our letter dated 26th March 2021 and pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the audited financial results for the quarter and year ended March 31, 2021 and recommendation of dividend, if any, for the year ending March 31, 2021, at its Meeting to be held on Wednesday, June 23, 2021. Further in accordance with the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window would continue to remain closed for Promoters, Directors, other connected persons and designated employees of the Company from April 1, 2021 till 48 hours after the announcement of financial results i.e., upto June 25 2021.
08-06-2021
Bigul

Apollo Hospitals Enterprise Ltd - 508869 - Board Meeting Intimation for Board Meeting For Approval Of Financial Results For The Period Ended March 31, 2021

APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2021 ,inter alia, to consider and approve Further to our letter dated 26th March 2021 and pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the audited financial results for the quarter and year ended March 31, 2021 and recommendation of dividend, if any, for the year ending March 31, 2021, at its Meeting to be held on Wednesday, June 23, 2021. Further in accordance with the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window would continue to remain closed for Promoters, Directors, other connected persons and designated employees of the Company from April 1, 2021 till 48 hours after the announcement of financial results i.e., upto June 25 2021.
08-06-2021

COVID-19 patients showing unusual symptoms doctors suspect Delta variant as cause: Report

Dr Abdul Ghafur, an infectious disease physician at the Apollo Hospital in Chennai told the publication that more scientific research is needed to analyse if the newer clinical presentations are linked to B.1.617 or not.
08-06-2021

Apollo Hospitals vaccinates about 1.5 million people so far

In Telangana, over 2 lakh persons got the jab at the hospital
05-06-2021

COVID-19 vaccination becomes more convenient as pvt hospitals, labs, pharmacy chains reach out to customers

Apollo Hospitals has completed 1 million vaccinations across 80 locations in India so far. It plans to make it into a million every week in June and double that in July. Karnataka permits even diagnostic chains. Only problem is that there is no cap on the vaccine administration fee.
02-06-2021

Apollo launches initiative to aid home-quarantined coronavirus patients

Apollo Hospitals on Tuesday announced an initiative to provide home-quarantined Covid-19 patients medical care
01-06-2021
Bigul

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 01, 2021 for Mrs Suneeta Reddy
01-06-2021

Delhi: 65-yr-old man becomes 1st patient to get antibody cocktail at Apollo

A 65-year-old man from Delhi, having multiple co-morbidities, has become the first COVID-19 patient to receive monoclonal antibody therapy at the Apollo hospital here, the healthcare group said on Friday. The patient responded well to the infusion of the antibody cocktail and went home after an hour of observation on Thursday, hospital authorities said. As part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Imdevimab, that is said to reduce their chance of hospitalisation by 70 per cent. In a statement, Indraprastha Apollo Hospitals, Delhi on Friday announced that "Roche India's antibody cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd. is available for administration to patients with mild and moderate COVID-19 infection" at its facility. The Antibody Cocktail was launched on May 24 in India by Roche India after receiving Emergency Use Authorisation (EUA) from the Central Drugs Standards
28-05-2021

Sputnik V Covid vaccine to be rolled out at Rs 1,195 in Apollo hospitals

India is moving towards vaccine sufficiency as inoculations with the Russian vaccine Sputnik V began in the country earlier this month.
28-05-2021
Next Page
Close

Let's Open Free Demat Account